Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy
Shuanghu Wang, Jian Xiao(Second Military Medical University), Zhenhong Su(Wuhan Polytechnic University), Binbin Cheng(Wenzhou Medical University), Chuxiao Shao(Wenzhou Medical University), Yiyu Lu(Southern Medical University), Wei Wang(Capital Medical University), Jianjun Chen(Southern Medical University), Jin Liu(Hubei Polytechnic University), Yingxing Zhou(Hubei Polytechnic University), Zhihua Kong(Guangdong Provincial Hospital of Traditional Chinese Medicine), Yaru Shi(Wenzhou Medical University), Xiaoting Fei(Hubei Polytechnic University)
Cited by 21
Related Papers
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257
Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration
|Acta Pharmacologica Sinica|2020|249
Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy
|Cell Death and Disease|2020|217
Neuron and microglia/macrophage-derived FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κB-dependent neuroinflammation to improve functional recovery after spinal cord injury
|Cell Death and Disease|2017|180
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
|Journal for ImmunoTherapy of Cancer|2020|153